Publication:

A case of molecularly profiled extraneural medulloblastoma metastases in a child

Loading...
Thumbnail Image

Open/View Files

Date

2018

Journal Title

Journal ISSN

Volume Title

Publisher

BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Mobark, Nahla Ali, Musa Al-Harbi, Othman Mosleh, Sandro Santagata, Matija Snuderl, and Malak Abedalthagafi. 2018. “A case of molecularly profiled extraneural medulloblastoma metastases in a child.” BMC Medical Genetics 19 (1): 10. doi:10.1186/s12881-018-0526-8. http://dx.doi.org/10.1186/s12881-018-0526-8.

Abstract

Background: Extraneural metastases are relatively rare manifestations of medulloblastoma. Case presentation: We present the case of a young boy with group three MYCN-amplified medulloblastoma. He received multimodal chemotherapy consisting of gross total resection followed by postoperative craniospinal radiation and adjuvant chemotherapy. The patient developed extraneural metastases 4 months after the end of therapy. Literature review identifies the poor prognosis of MYCN-amplified medulloblastomas as well as extraneural metastases; we review the current limitations and future directions of medulloblastoma treatment options. Conclusion: To the best of our knowledge, this is the first molecularly characterized report of extraneural metastases of medulloblastoma in a child.

Description

Research Data

Keywords

Extraneural metastasis, Medulloblastoma, NGS, Methylation

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories